A quote from this excellent piece, neatly summarising a core impact of Brexit.
The Commission’s view, according to several sources, is that Brexit means existing distribution networks and supply chains are now defunct and will have to be replaced by other systems.
Brexit reality bites: The new dawn of trade friction via @RTENews https://t.co/p6VdlhZUAN
— Tony Connelly (@tconnellyRTE) January 9, 2021
More from Objective Columnist
Still, he's taken a very big step back now. The cliff risk was today; both sides were so close to the edge they could easily have gone over it. The fact @10DowningStreet didn't means Govt must genuinely believe there's now a landing zone that works, & which it can sell ENDS
— Mujtaba Rahman (@Mij_Europe) December 13, 2020
I find it most amusing that people invest so much value in public statements, briefings, tabloid headlines, the tweets of obscure backbenchers etc. Cherchez les fundamentals!
There is a deep vein of analytical pessimism in one particular direction, which, whether correct or not, is noteworthy. On the one hand, a firm belief in the fundamentals - gravity exists - but on the other hand those fundamentals are not meaningful to the final decision.
But gravity does exist! Whether one likes it or not. We do not have wings. Or feathers. And the realisation of the fundamentals will impact the political calculation (though timing differences may apply).
You don’t have to invest any particular optimism or see any virtue in the principal players to make this point.
More from Brexit
London intends to make use of its costly SPS regulatory autonomy. As widely anticipated, first area of divergence expected to take place in the field of Crispr technology for genome editing, area where the UK has long argued for a more liberal stance.https://t.co/btRoxU3saZ
— Emily Rees (@emilyrees_eu) January 7, 2021
Let's start off with: I don't think any trade experts are surprised by this. It is why the TCA did not do much on SPS. It is why the EU did not offer much on SPS. It is why the UK did not ask much on SPS.
But it also shows that the popular slogan "after Brexit we'll have the same standards as before, so why would anything change in trade" was wrong - and worse, it was purposefully trying to stifle a necessary debate.
And this leads me to the next point: I have no issue with changing the rules, I have a massive issue with how it is done. Here's what we should discuss:
The decisive question: What are the standards the UK as a country wants. To inform this debate, we need the following information:
You May Also Like
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj

@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
